← All news
Markets
Scancell (LSE:SCLP) secures BlackRock-backed debt this week: can the cancer vaccine developer accelerate its trial?
Highlights Scancell has agreed a multi-tranche loan facility with funds and accounts managed by BlackRock. Drawdowns are conditional on shareholder approval and milestones tied to its US listing and trial start. The funding supports the reg…
Covered by 1 outlet
All coverage · 1 article